Immunohistochemical analysis of CD56+ infiltrating-NK cells in biopsy specimens of BC patients revealed a poor tumor infiltration, independently of tumor stage and grade, reflecting an inefficient homing of NK cells in BC, unlikely to control tumor progression. This evidence concerns the gene NCAM1 and neoplasm.